RxDoctor Payments Data

John Farmer, MD

Family Medicine · Madisonville, KYNPI 1285695866

Payments from drug & device makers

$331in general payments, 2019–2025

Across 17 payments — averaging $19.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$119
  • Amgen$71
  • AbbVie$55
  • GSK$40
  • Pfizer$15
  • Novo Nordisk$12
  • plus $19 from 2 others

What the payments were for

  • Food & beverage$22066%
  • Education$11234%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc2$119
Amgen5$71
AbbVie(2 entities)3$55
GSK3$40
Pfizer1$15
Novo Nordisk1$12
AstraZeneca1$12
Phathom Pharmaceuticals, Inc.1$8

How this compares

$331 in reported general payments places this provider in the 35th percentile of 1,559 family medicine providers in Kentucky.

See all family medicine providers in Kentucky

Medicare billing

Part B allowed, 2024
$227,767
Medicare patients
580
Services billed
4,190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban325$220,670
OzempicSemaglutide152$178,013
MounjaroTirzepatide110$119,366
JardianceEmpagliflozin96$107,912
XareltoRivaroxaban62$46,972
FarxigaDapagliflozin Propanediol36$43,600
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog57$40,608
LinzessLinaclotide38$40,432
XifaxanRifaximin28$38,952
Trelegy ElliptaFluticasone/Umeclidin/Vilanter36$34,007
JanuviaSitagliptin Phosphate52$32,975
MyrbetriqMirabegron60$29,489
JanumetSitagliptin Phos/Metformin Hcl21$28,677
TrulicityDulaglutide23$27,171
Breztri AerosphereBudesonide/Glycopyr/Formoterol39$25,775

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$220,670325 claims
Novo NordiskOzempic$12$178,013152 claims
AstraZenecaFarxiga, Breztri Aerosphere$12$69,37575 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arexvy$40$67,545100 claims
AbbVieLinzess$55$40,43238 claims
Astellas Pharma US IncMyrbetriq$119$29,48960 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,559 family medicine providers in Kentucky.

Other family medicine in Madisonville

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →